Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3039450, 16 pages
https://doi.org/10.1155/2017/3039450
Research Article

Compound Wumei Powder Inhibits the Invasion and Metastasis of Gastric Cancer via Cox-2/PGE2-PI3K/AKT/GSK3β/β-Catenin Signaling Pathway

1The Affiliated Hospital of Nanjing University of TCM, Jiangsu Province Hospital of TCM, Nanjing 210029, China
2No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China
3The Affiliated Hospital of Nanjing University of TCM, Liyang Hospital of TCM, Changzhou 213300, China

Correspondence should be addressed to Xi Zou; moc.621@rdixuoz

Received 16 July 2017; Revised 22 September 2017; Accepted 2 October 2017; Published 21 November 2017

Academic Editor: Jian-Li Gao

Copyright © 2017 Nai-Xia Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. W.-M. Kang, Q.-B. Meng, J.-C. Yu, Z.-Q. Ma, and Z.-T. Li, “Factors associated with early recurrence after curative surgery for gastric cancer,” World Journal of Gastroenterology, vol. 21, no. 19, pp. 5934–5940, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Song, H. Su, Y.-Y. Zhou, and L.-L. Guo, “Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis,” Digestive Diseases and Sciences, vol. 59, no. 2, pp. 436–445, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Misra and K. Sharma, “COX-2 signaling and cancer: new players in old arena,” Current Drug Targets, vol. 15, no. 3, pp. 347–359, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lian, Y. Xia, T. T. Ung et al., “Prostaglandin E2 stimulates urokinase-type plasminogen activator receptor via EP2 receptor-dependent signaling pathways in human AGS gastric cancer cells,” Molecular Carcinogenesis, vol. 56, no. 2, pp. 664–680, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Dai, C. Qian, M. Su, M. Chen, and J. Chen, “Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer,” Tumor Biology, vol. 37, no. 9, pp. 12403–12410, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Hu, L. Xiao, C. Cao, S. Hua, and D. Wu, “UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSKβ/β-catenin pathway,” Oncotarget , vol. 7, no. 12, pp. 15161–15172, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-O. Son, L. Wang, P. Poyil et al., “Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling,” Toxicology and Applied Pharmacology, vol. 264, no. 2, pp. 153–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Zhang, C. Yin, H. Li et al., “Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway,” European Journal of Cancer, vol. 49, no. 18, pp. 3900–3913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Zhao, H.-C. Miao, W.-J. Li et al., “LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells,” Molecular Carcinogenesis, vol. 55, no. 5, pp. 778–792, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kim, C. H. Kim, D.-W. Ahn et al., “Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling,” Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 480–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Mori, K. Mimori, T. Shiraishi et al., “Analysis of MT1-MMP and MMP2 expression in human gastric cancers,” International Journal of Cancer, vol. 74, no. 3, pp. 316–321, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Sakamoto, Y. Naito, N. Oue et al., “MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis,” Cancer Science, vol. 105, no. 2, pp. 236–243, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Zarrabi, A. Dufour, J. Li et al., “Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated cancer cell migration,” The Journal of Biological Chemistry, vol. 286, no. 38, pp. 33167–33177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Dong, G. Chen, M. Gao, and X. Tian, “Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer,” Gene, vol. 563, no. 1, pp. 29–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Takino, Y. Watanabe, M. Matsui et al., “Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration,” Experimental Cell Research, vol. 312, no. 8, pp. 1381–1389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Li, Z. Mao, X. Fan, L. Cui, and X. Wang, “Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells,” Tumor Biology, vol. 35, no. 3, pp. 2271–2278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Shalaby, H. A. Nounou, M. S. Alanazi, O. Alharby, N. Azzam, and H. M. Saeed, “Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the saudi population,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 12, pp. 4989–4994, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Xin, M. Majumder, G. V. Girish, V. Mohindra, T. Maruyama, and P. K. Lala, “Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model,” Laboratory Investigation, vol. 92, no. 8, pp. 1115–1128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Du, F. Shi, H. Zhang et al., “Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor,” Oncology Reports, vol. 34, no. 2, pp. 715–726, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Liu, Y. Zhang, R. Xu et al., “PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration,” Cellular Signalling, vol. 25, no. 2, pp. 447–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. T. Chan, E. L. Giovannucci, J. A. Meyerhardt, E. S. Schernhammer, K. Wu, and C. S. Fuchs, “Aspirin dose and duration of use and risk of colorectal cancer in men,” Gastroenterology, vol. 134, no. 1, pp. 21–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Farooqui, Y. Li, T. Rogers et al., “COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia,” British Journal of Cancer, vol. 97, no. 11, pp. 1523–1531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-X. Ni, Y. Qi, J. Zhang et al., “WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway,” Oncotarget , vol. 7, no. 48, pp. 79544–79556, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Sun, C. Gao, M. Luo et al., “Aspidin PB, a phloroglucinol derivative, induces apoptosis in human hepatocarcinoma HepG2 cells by modulating PI3K/Akt/GSK3β pathway,” Chemico-Biological Interactions, vol. 201, no. 1–3, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Wang, C.-C. Feng, S.-J. Chu et al., “Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway,” International Journal of Oncology, vol. 47, no. 5, pp. 1767–1774, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Bishnupuri, S. K. Sainathan, K. Bishnupuri et al., “Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer,” Molecular Carcinogenesis, vol. 53, no. 1, pp. E169–E180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Wu, H. Zhang, C. Xu et al., “TIPE2 functions as a metastasis suppressor via negatively regulating catenin through activating GSK3 in gastric cancer,” International Journal of Oncology, vol. 48, no. 1, pp. 199–206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Velinov, G. Poptodorov, N. Gabrovski, and S. Gabrovski, “The role of matrixmetalloproteinases in the tumor growth and metastasis,” Khirurgiia, no. 1, pp. 44–49, 2010. View at Google Scholar · View at Scopus